Seqirus Inc.
Holly Springs, NC Seqirus Inc.
- UEI
- Z6N1LJ2RD6E3
- CAGE
- 7L0Y8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 475 Green Oaks Pkwy, Holly Springs, NC 27540, USA
- Website
- cslseqirus.us
- Founded
- 1916
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Seqirus Inc.
Seqirus Inc., a foreign-owned manufacturer of vaccines and medical countermeasures, operates as a prime contractor exclusively with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR), delivering pandemic preparedness vaccines and clinical trial support from its manufacturing facility in Holly Springs, North Carolina. The vendor holds no subcontract footprint — all 45 federal awards in the source are prime awards issued directly by HHS ASPR, and the vendor has never competed under set-asides.
Seqirus's federal footprint is anchored entirely to a single $13.4 billion Indefinite Delivery Contract awarded by HHS ASPR on February 22, 2022, with an ultimate completion date of February 21, 2027. Under this parent IDC, ASPR has issued 13 task orders carrying $438.5 million in combined potential value. The vendor's capability scope encompasses cGMP manufacturing of influenza vaccine master and working seed lots (up to three lots annually), formulation and filling of at least 50 million vaccine doses annually, stability testing and storage of vaccine stockpiles, and specialized research support including physical and chemical compatibility studies and immunogenicity testing. Representative work includes a $349.3 million delivery order issued May 3, 2024, for H5 pandemic readiness medical countermeasures acquisition; a $30.7 million order from September 19, 2022, for influenza A/Astrakhan/3212/2020 (H5N8)-like master and working seed lots and clinical trial support; a $28.5 million order from June 27, 2023, for H5N8 antigen acquisition and formulation; and a $23.3 million order from February 22, 2024, for storage and stability testing of vaccine bulk lots. Recent delivery orders issued in 2026 include a $564,952 order from May 7, 2026, for extractable and leachable studies and a $450,052 order from April 2, 2026, for immunogenicity testing on clinical trial sera.
Customer concentration is absolute and non-diversified: HHS ASPR accounts for all 45 awards and the full $34.86 billion in combined potential value. Only four awards face ultimate completion inside the next twenty-four months, carrying combined potential value of $45.5 million and triggering recompete exposure in that window. The vendor's federal contracting activity has been episodic rather than sustained — one award in 2021, five in 2022, three in 2023, four in 2024, and two in 2026 — reflecting the task-order cadence driven by pandemic preparedness requirements and HHS ASPR's strategic stockpile acquisition needs rather than continuous program growth. As a division of CSL Seqirus, the vendor represents a subsidiary relationship within a global biotechnology corporation, though the source does not detail the corporate ownership structure beyond the "foreign-owned" designation.
Contract vehicles
Quick answers
What is Seqirus Inc.'s UEI?
Seqirus Inc.'s Unique Entity ID (UEI) in SAM.gov is Z6N1LJ2RD6E3.
What is Seqirus Inc.'s CAGE code?
Seqirus Inc.'s CAGE code is 7L0Y8.
What is Seqirus Inc.'s primary NAICS code?
Seqirus Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Seqirus Inc. located?
Seqirus Inc.'s physical address in SAM.gov is 475 Green Oaks Pkwy, Holly Springs, NC 27540, USA.
Is Seqirus Inc. registered in SAM.gov?
Yes. Seqirus Inc.'s SAM.gov registration is active through November 13, 2026.
Which contract vehicles does Seqirus Inc. hold?
Seqirus Inc. holds a place on 1 federal contract vehicle: Pandemic Influenza Preparedness and Response 2012-2016.
What is Seqirus Inc.'s most recent federal award?
Seqirus Inc.'s most recent federal contract award is Manufacture and stability studies of thimerosal-free pandemic influenza vaccine multidose vials (mdvs) (75A50126F61014), from Office of the Assistant Secretary for Preparedness and Response, on September 30, 2026.
On GovTribe
See Seqirus Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors